425: Strive & Semler Scientific Merger Communication

Strive, Inc. posted a communication on X.com regarding its proposed business combination with Semler Scientific, Inc., including cautionary forward-looking statements.

Summary

• Strive, Inc. (Strive) posted a communication on X.com by its CEO, Matthew Cole, on October 28, 2025, concerning its proposed business combination with Semler Scientific, Inc. (Semler Scientific).
• The communication serves as a Form 425 filing, related to the merger.
• It includes a 'Cautionary Statement Regarding Forward-Looking Statements' detailing inherent risks and uncertainties associated with the transaction.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement of Strive, proxy statement of Semler Scientific and a prospectus of Strive for Semler Scientific stockholders' approval.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when available.
• Strive, Semler Scientific, and certain directors/executive officers may be deemed participants in the solicitation of proxies.
• The communication is not an offer to sell or a solicitation of an offer to buy any securities or a solicitation of any vote of approval.

Sentiment

Score: 4

Explanation: The filing is primarily a cautionary statement about a proposed merger, heavily emphasizing numerous risks and uncertainties. While it mentions potential strategic and financial benefits, the overwhelming focus is on potential negative outcomes, delays, and integration challenges, leading to a cautious sentiment.

Positives

• The proposed transaction aims for strategic and financial benefits for the combined company.

Negatives

• The proposed transaction may not close when expected or at all.
• Anticipated benefits, including cost savings and strategic gains, may not be realized.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Potential adverse reactions from customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both of Strive and Semler Scientific to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all, including as a result of changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact anticipated benefits.
• The possibility that the integration of the two companies may be more difficult, time-consuming or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific or the combined company, including unknown or unpredictable factors.

Future Outlook

The filing contains forward-looking statements regarding the outlook and expectations of Strive and Semler Scientific concerning the proposed transaction, including anticipated strategic and financial benefits, the timing of closing, and the ability to successfully integrate the combined businesses. However, it heavily cautions that actual results may differ materially from these expectations due to various risks and uncertainties.

Management Comments

• Matthew Cole, CEO of Strive, Inc., posted a communication on X.com regarding the proposed business combination.

Industry Context

This filing is a standard procedural step in a proposed merger between two companies. The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests that at least one of the companies (likely Semler Scientific, given its past public statements) has exposure to or plans for digital asset investments, which is a notable trend for some public companies.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a risk factor.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in its definitive proxy statement for its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Shareholders of Strive: Potential dilution from issuance of new Class A common stock.
• Shareholders of Semler Scientific: Will receive Strive Class A common stock, subject to approval.
• Customers of Strive and Semler Scientific: Potential adverse reactions or changes to business relationships.
• Employees of Strive and Semler Scientific: Potential changes to employee relationships.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement of Strive, proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Recommendation

This filing is a procedural disclosure for a proposed merger, not a financial performance update. While mergers can be value-accretive, this specific document heavily emphasizes the numerous risks, uncertainties, and potential for delays or failure to realize anticipated benefits. The mention of dilution for Strive shareholders and the extensive list of cautionary statements suggest a cautious approach. Without more specific financial terms or a clearer path to synergy realization, a 'hold' recommendation is appropriate, advising investors to await further details in the S-4 filing and monitor progress, given the significant risks outlined.

Keywords

Strive, Semler Scientific, merger, acquisition, business combination, SEC filing, Form 425, forward-looking statements, Bitcoin, digital assets, corporate governance, proxy solicitation